Literature DB >> 11744631

Identification of a nonmucin glycoprotein (gp-340) from a purified respiratory mucin preparation: evidence for an association involving the MUC5B mucin.

D J Thornton1, J R Davies, S Kirkham, A Gautrey, N Khan, P S Richardson, J K Sheehan.   

Abstract

Rate-zonal centrifugation of a reduced and alkylated respiratory mucin preparation identified a protein-rich fraction. This was subjected to trypsin treatment and one of the many liberated peptides was purified and its N-terminal sequence determined. The peptide was identical to a 14 amino acid sequence from the scavenger receptor cysteine-rich domain containing glycoprotein gp-340. A polyclonal antiserum, raised against the peptide, stained the serous cells in the submucosal glands of human tracheal tissue. The glycoprotein was purified from respiratory mucus by density-gradient centrifugation, gel chromatography, and anion exchange chromatography. The molecule exhibited a heterogeneous distribution of buoyant density (1.28-1.46 g/ml) that overlapped with the gel-forming mucins, was included on Sepharose CL-2B and was quite highly anionic. SDS-PAGE indicated a mass greater than 208 kDa and measurements performed across the molecular size distribution indicated an average M(r) of 5 x 10(5) with a range of M(r) from 2 x 10(5) to 1 x 10(6). Gel chromatography of respiratory mucus extracts ("associative" and "dissociative") indicated that this glycoprotein forms complexes that may involve the large gel-forming mucins MUC5AC and MUC5B. Rate zonal centrifugation suggested such complexes are more likely to involve MUC5B rather than MUC5AC mucins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744631     DOI: 10.1093/glycob/11.11.969

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  22 in total

1.  Binding of salivary agglutinin to IgA.

Authors:  Antoon J M Ligtenberg; Floris J Bikker; Jolanda M A De Blieck-Hogervorst; Enno C I Veerman; Arie V Nieuw Amerongen
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

2.  Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation.

Authors:  Christer Eriksson; Lars Frängsmyr; Liza Danielsson Niemi; Vuokko Loimaranta; Ulf Holmskov; Tomas Bergman; Hakon Leffler; Howard F Jenkinson; Nicklas Strömberg
Journal:  Glycoconj J       Date:  2007-01-23       Impact factor: 2.916

Review 3.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

4.  Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.

Authors:  Benjamin L Schulz; Andrew J Sloane; Leanne J Robinson; Lucille T Sebastian; Allan R Glanville; Yuanlin Song; Alan S Verkman; Jenny L Harry; Nicolle H Packer; Niclas G Karlsson
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

5.  Decreased gastric bacterial killing and up-regulation of protective genes in small intestine in gastrin-deficient mouse.

Authors:  Francis J Sun; Simran Kaur; Donna Ziemer; Snigdha Banerjee; Linda C Samuelson; Robert C De Lisle
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

6.  Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis.

Authors:  Motoko Sasaki; Shiu-Feng Huang; Miin-Fu Chen; Yi-Yin Jan; Ta-Sen Yeh; Akira Ishikawa; Jan Mollenhauer; Annemarie Poustka; Koichi Tsuneyama; Yuji Nimura; Koji Oda; Yasuni Nakanuma
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

7.  Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.

Authors:  Ashley G Henderson; Camille Ehre; Brian Button; Lubna H Abdullah; Li-Heng Cai; Margaret W Leigh; Genevieve C DeMaria; Hiro Matsui; Scott H Donaldson; C William Davis; John K Sheehan; Richard C Boucher; Mehmet Kesimer
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

8.  E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion.

Authors:  Boris Reidel; Giorgia Radicioni; Phillip W Clapp; Amina A Ford; Sabri Abdelwahab; Meghan E Rebuli; Prashamsha Haridass; Neil E Alexis; Ilona Jaspers; Mehmet Kesimer
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

Review 9.  Deleted in malignant brain tumors-1 protein (DMBT1): a pattern recognition receptor with multiple binding sites.

Authors:  Antoon J M Ligtenberg; Niclas G Karlsson; Enno C I Veerman
Journal:  Int J Mol Sci       Date:  2010-12-17       Impact factor: 5.923

10.  A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3).

Authors:  Jens Madsen; Grith Lykke Sorensen; Ole Nielsen; Ida Tornøe; Lars Thim; Claus Fenger; Jan Mollenhauer; Uffe Holmskov
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.